All Updates

All Updates

icon
Filter
Funding
Rivia raises EUR 3 million in seed funding
Clinical Trial Technology
Jun 12, 2024
This week:
Partnerships
Anthropic partners with Amazon Bedrock to fine-tune Claude 3 Haiku model
Foundation Models
Yesterday
Funding
Lemon.markets raises EUR 12 million in funding to support growth
FinTech Infrastructure
Yesterday
M&A
Kipu Quantum acquires PlanQK platform to enhance accessibility to quantum computing solutions
Quantum Computing
Yesterday
Partnerships
Quantinuum and STFC Hartree Centre partner to enhance quantum computing accessibility in UK
Quantum Computing
Yesterday
M&A
Ipsen licenses Foreseen's antibody-drug conjugate 'FS001' for first-in-class cancer treatment development
Precision Medicine
Yesterday
M&A
Ipsen licenses Foreseen's antibody-drug conjugate 'FS001' for first-in-class cancer treatment development
AI Drug Discovery
Yesterday
Partnerships
Beacon Therapeutics collaborates with Abeona Therapeutics for ophthalmic gene therapy development
Cell & Gene Therapy
Yesterday
Funding
Pan Cancer T raises EUR 4.25 million in seed extension funding for preclinical studies of PCT1:CO-STIM TCR T-cell therapy
Cell & Gene Therapy
Yesterday
Partnerships
Accelerated Biosciences and Pluristyx partner to create clinical-grade induced pluripotent stem cell lines
Cell & Gene Therapy
Yesterday
M&A
SoftBank acquires UK AI chipmaker Graphcore to improve AI capabilities
Edge Computing
Yesterday
Clinical Trial Technology

Clinical Trial Technology

Jun 12, 2024

Rivia raises EUR 3 million in seed funding

Funding

  • Rivia, a Swiss bio-analytics startup, has secured EUR 3 million (USD 3.2 million) in a seed funding round led by Speedinvest, alongside Amino Collective and Nina Capital.

  • The funds will be used to hire new engineering and client services team members. Additionally, the company plans to use part of the funds to advance its product development and strengthen its market position.

  • Based in Switzerland, Rivia specializes in providing a platform for clinical trial data integration and management. Its platform provides real-time insights and improves trial management efficiency by centralizing diverse data sources into a single, cohesive view.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.